TRI-Luma Related Published Studies
Well-designed clinical trials related to TRI-Luma (Fluocinolone / Hydroquinone / Tretinoin)
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. [2008.09]
A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma. [2008.06.28]
A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma. [2007.03]
A large 12-month extension study of an 8-week trial to evaluate the safety and efficacy of triple combination (TC) cream in melasma patients previously treated with TC cream or one of its dyads. [2005.09]
Efficacy and safety of a new triple-combination agent for the treatment of facial melasma. [2003.07]
Well-designed clinical trials possibly related to TRI-Luma (Fluocinolone / Hydroquinone / Tretinoin)
A hydroquinone formulation with increased stability and decreased potential for irritation. [2007.06]
Other research related to TRI-Luma (Fluocinolone / Hydroquinone / Tretinoin)
Successful treatment of moderate to severe melasma with triple-combination cream and glycolic acid peels: a pilot study. [2008.11]
Cost-effectiveness of a fixed combination of hydroquinone/tretinoin/fluocinolone cream compared with hydroquinone alone in the treatment of melasma. [2007.02]
Validation of a melasma quality of life questionnaire for Brazilian Portuguese language: the MelasQoL-BP study and improvement of QoL of melasma patients after triple combination therapy. [2006.12]
Community-based trial of a triple-combination agent for the treatment of facial melasma. [2006.03]
Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma. [2005.01]
Improved quality of life with effective treatment of facial melasma: the pigment trial. [2004.07]
Gateways to clinical trials. [2004.04]
Other possibly related research studies
Utilizing combination therapy to optimize melasma outcomes. [2004.09]
Rationale for the use of topical corticosteroids in melasma. [2004.03]
Postinflammatory hyperpigmentation: evolving combination treatment strategies. [2006.08]
Ethnic considerations in the treatment of Hispanic and Latin-American patients with hyperpigmentation. [2006.12]
An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma. [2007.12]
Hyperpigmentation: old problem, new therapies. [2009.09]
|
